News Headlines Article

House panel debates Creates Act, ‘pay-for-delay’
Modern Healthcare

A U.S. House of Representatives health panel on Wednesday became the first in this Congress to work on prescription drug legislation, including the Creates Act and a ban on “pay for delay” deals, as lawmakers eye a forthcoming bicameral package to lower pharmaceutical prices.

The packet of bills from the House Energy and Commerce health subcommittee takes oblique aim at brand drugs’ patent and exclusivity privileges to push more generic competition, and represents a gentle first step in the growing congressional momentum to scrutinize the entire drug patent system.